Edap Tms SA
EDAP4.730USD
+0.730+18.25%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
176.86MMarket Cap
LossP/E TTM
More Details of Edap Tms SA Company
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Edap Tms SA Info
Ticker SymbolEDAP
Company nameEdap Tms SA
IPO dateAug 01, 1997
CEORhodes (Ryan)
Number of employees310
Security typeDepository Receipt
Fiscal year-endAug 01
Address4, rue du Dauphine
CityVAULX-EN-VELIN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryFrance
Postal code69120
Phone33472153150
Websitehttps://focalone.com/fr/accueil/
Ticker SymbolEDAP
IPO dateAug 01, 1997
CEORhodes (Ryan)
Company Executives of Edap Tms SA
Name
Name/Position
Position
Shareholding
Change
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.24M
+1241780.00%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
301.15K
+301149.00%
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
Ms. Blandine Confort
Ms. Blandine Confort
Investor Relations Officer, Director - Legal Affairs
Investor Relations Officer, Director - Legal Affairs
--
--
Mr. Francois Dietsch
Mr. Francois Dietsch
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Ken Mobeck
Mr. Ken Mobeck
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
--
--
Mr. Glen French
Mr. Glen French
Independent Director
Independent Director
--
--
Mr. Joshua H. (Josh) Levine
Mr. Joshua H. (Josh) Levine
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.24M
+1241780.00%
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
301.15K
+301149.00%
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
Ms. Blandine Confort
Ms. Blandine Confort
Investor Relations Officer, Director - Legal Affairs
Investor Relations Officer, Director - Legal Affairs
--
--
Mr. Francois Dietsch
Mr. Francois Dietsch
Chief Accounting Officer
Chief Accounting Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2024
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Asia
19.04M
29.70%
United States
18.22M
28.42%
Other Geographical Areas
15.61M
24.35%
France
11.24M
17.53%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Soleus Capital Management, L.P.
19.55%
Morgan Stanley & Co. International Plc
8.99%
Rock Springs Capital Management LP
3.40%
Willsey (Lance)
3.32%
Bruce & Company, Inc.
1.17%
Other
63.57%
Shareholders
Shareholders
Proportion
Soleus Capital Management, L.P.
19.55%
Morgan Stanley & Co. International Plc
8.99%
Rock Springs Capital Management LP
3.40%
Willsey (Lance)
3.32%
Bruce & Company, Inc.
1.17%
Other
63.57%
Shareholder Types
Shareholders
Proportion
Hedge Fund
23.94%
Research Firm
9.07%
Individual Investor
4.42%
Investment Advisor
4.14%
Investment Advisor/Hedge Fund
0.23%
Bank and Trust
0.01%
Other
58.18%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
67
13.87M
40.98%
--
2025Q3
75
13.87M
43.87%
-275.79K
2025Q2
87
14.15M
45.65%
-604.14K
2025Q1
89
14.75M
47.73%
-3.10M
2024Q4
92
15.39M
47.99%
-286.99K
2024Q3
91
15.67M
50.30%
-364.48K
2024Q2
88
16.06M
51.11%
-201.29K
2024Q1
93
16.22M
51.99%
-3.07M
2023Q4
90
15.98M
53.82%
-494.00
2023Q3
93
15.98M
53.21%
-272.41K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Soleus Capital Management, L.P.
7.31M
19.55%
--
--
Sep 30, 2025
Morgan Stanley & Co. International Plc
3.36M
8.99%
-800.00
-0.02%
Sep 30, 2025
Rock Springs Capital Management LP
1.27M
3.4%
--
--
Sep 30, 2025
Bruce & Company, Inc.
438.65K
1.17%
-115.00K
-20.77%
Sep 30, 2025
UBS Financial Services, Inc.
234.44K
0.63%
+59.77K
+34.22%
Sep 30, 2025
Schonfeld Strategic Advisors LLC
170.06K
0.45%
-2.08K
-1.21%
Sep 30, 2025
Parkman Healthcare Partners LLC
154.83K
0.41%
--
--
Sep 30, 2025
Cahill Financial Advisors, Inc.
134.96K
0.36%
--
--
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ActivePassive International Equity ETF
0%
ActivePassive International Equity ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
